Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-01-03 @ 8:16 PM
Study NCT ID:
NCT02831660
Status:
COMPLETED
Last Update Posted:
2018-03-20
First Post:
2016-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CU Programme of Idarucizumab for Japanese Patients
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-07-22
Start Date Type:
ACTUAL
Primary Completion Date:
2016-09-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09-16
Completion Date Type:
ACTUAL
First Submit Date:
2016-07-11
First Submit QC Date:
None
Study First Post Date:
2016-07-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-18
Results First Submit QC Date:
None
Results First Post Date:
2018-03-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-03-19
Last Update Post Date:
2018-03-20
Last Update Post Date Type:
ACTUAL